Thomas F. Kearns Jr. is Director at FIBROGEN INC (FGEN). They have made 7 open-market trades across 1 company since 2015, most recently 2021-09-15.
CIK 0001189184
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FGEN | SELL | 2021-09-15 | 2021-09-17 | $11.58 | $152K | -9.3% | -6.0% | +23.1% |
| FGEN | SELL | 2021-03-11 | 2021-03-15 | $35.02 | $630K | -6.9% | -42.8% | -23.3% |
| FGEN | SELL | 2020-03-19 | 2020-03-23 | $23.17 | $834K | +22.1% | +36.0% | +51.0% |
| FGEN | SELL | 2018-03-12 | 2018-03-13 | $55.00 | $990K | -12.2% | -8.5% | +7.8% |
| FGEN | SELL | 2017-11-15 | 2017-11-17 | $45.22 | $814K | +1.4% | -7.5% | +20.5% |
| FGEN | SELL | 2017-06-06 | 2017-06-08 | $28.71 | $517K | +3.4% | +11.7% | +65.0% |
| FGEN | SELL | 2016-11-17 | 2016-11-18 | $22.40 | $403K | -11.6% | -13.8% | +4.9% |
| FGEN | SELL · 10b5-1 | 2016-01-21 | 2016-01-22 | $22.08 | $35K | -12.8% | -7.9% | -3.1% |
| FGEN | SELL · 10b5-1 | 2015-12-23 | 2015-12-28 | $30.88 | $241K | -21.7% | -35.3% | -36.2% |
| FGEN | SELL · 10b5-1 | 2015-11-23 | 2015-11-25 | $28.51 | $222K | -21.7% | +2.4% | -39.6% |
| FGEN | SELL · 10b5-1 | 2015-10-20 | 2015-10-22 | $23.83 | $186K | -21.7% | +2.4% | -27.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.